Dan Albertson, MD, will serve as president of the University Business Unit.
Varex Imaging has entered into a senior secured revolving credit agreement for an initial aggregate principal amount of up to $155 million.
Most Americans Unaware of Challenges from Common Hospital Procedures
BD Named Among Fortune’s Most Innovative Companies
Dual 510(k) clearance and CLIA-waiver approval for the BIOFIRE® SPOTFIRE® R/ST Panel
Pivotal Trial for Improving Overall Function and Quality of Life
Spectrum Solutions® Releases the New SimplyPERIO™ Saliva Test Powered by SimplyTest®
SALT LAKE CITY, UT, March 19, 2024 (Business Wire) – Seek Labs, a healthcare innovations company developing next-generation molecular diagnostic systems and novel CRISPR-based gene therapies, is pleased to announce the appointment of Michael Paul, PhD to its Board of Directors, effective March 18, 2024. With decades of experience in life sciences innovation, capital formation, […]
SALT LAKE CITY, March 21, 2024 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that the United States Patent and Trademark Office has issued a patent that will strengthen its ability to deliver a tumor-informed, high-definition, molecular residual disease (MRD) assay to market. U.S. patent […]
HEBER CITY, Utah, Feb. 13, 2024 /PRNewswire/ — Wasatch Biolabs (WBL), a subsidiary of Renew Biotechnologies and a certified Oxford Nanopore Technologies’ laboratory, launches a proprietary Targeted DNA Methylation Sequencing Service for researchers and clinical service providers. The technique is amplification and bisulfite conversion free, effectively bypassing the most common limitations of targeted methylation analysis […]
Presentation included announcement of the opening of the new manufacturing facility in Salt Lake City, UT SALT LAKE CITY, March 21, 2024 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that in his keynote address […]
VALENCIA, Calif. – March 20, 2024 – Nusano, a physics company transforming the production of medical radioisotopes, will present at the 7th Theranostics World Congress taking place March 22-24, 2024, in Santiago, Chile. Greg Moffitt, Nusano Director of Target Development, will provide an overview of the company’s proprietary radioisotope production platform on Sunday, March 24. […]
Micro ACE combines a unique balance of stiffness and resiliency to achieve successful micro-access in challenging cases SOUTH JORDAN, Utah, March 19, 2024 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced commercial release of its US Food and Drug Administration (FDA)-cleared Micro ACE Advanced Micro-Access System. […]
Myriad Genetics Announces Patent Granted for SneakPeek® Snap Device
Successful Completion of Upsized $12M Placing NEW YORK and SALT LAKE CITY, March 12, 2024 – Renalytix plc (NASDAQ: RNLX) (LSE: RENX) is pleased to announce that following its announcement earlier today regarding a proposed Placing of Ordinary Shares (the “Launch Announcement“), it has successfully placed 46,801,872 Ordinary Shares (the “Placing Shares“) with both UK and US institutional […]
The clinical laboratory real-time PCR multiplex test was designed using Co-Dx Co-Primers™ and licensed by the CDSCO for use in diagnostic procedures
LARGE, REAL-WORLD STUDIES DEMONSTRATE CONTINUED EXCELLENT OUTCOMES FOR PATIENTS RECEIVING EDWARDS SAPIEN TAVR
LU-177 SHIPMENTS EXPECTED TO BEGIN EARLY 2025, FOLLOWED BY AC-225
Appoints Michael Bronstein as Scientific Advisor and launches recruiting effort to fill the first 20 open roles across technology and biology, establishing a hub for world-class TechBio talent in the heart of King’s Cross neighborhood
Partnership closes gaps in care for high-needs commercial, Medicaid and Medicare populations
Presentation to be held on Tuesday, March 19, from 11:30 a.m. – 11:45 a.m. CET
Fabric Genomics Partners with Intermountain Children’s Health to Enhance Precision Diagnosis of Infants and Children
Guidelines highlight the importance of risk prediction and personalized treatment to reduce risk
Final Amendments to Strengthen Air Toxics Standards for Ethylene Oxide Commercial Sterilizers
Carterra technology will allow Ordaōs to accelerate its mission of leveraging advanced technologies to efficiently and effectively design novel life-changing therapies for patients in need.
It was another banner year for the Wilson Sonsini Entrepreneur & Investor Life Sciences Summit (E&I Summit), presented by BioUtah and the University of Utah Technology Licensing Office. The 2024 E&I Summit included activities from March 13-15 with the main Summit event held, March 14 at the Sheraton in Salt Lake City. Over 450 registrants […]
Cellvizio Food Intolerance Test (C-FIT) delivers real-time, in vivo visibility to accurately identify food intolerance in patients suffering from Irritable Bowel Syndrome (IBS) Metrodora will serve as Center of Excellence for patient care and physician training to enable broad access to this breakthrough procedure Paris, Boston and Salt Lake City, March 6, 2024 – 5:45 […]
BOSTON, March 4, 2024 /PRNewswire/ — Constant Therapeutics LLC, a biopharmaceutical company focused on the development of treatments impacting the Alternative Renin-Angiotensin System, today announced that the first patient was dosed March 3, 2024, in the Company’s phase 2 clinical trial of TXA127, the Company’s lead peptide product under development as a potential treatment for […]
Offer Now Scheduled to Expire at 5:00 p.m., New York Time, on April 30, 2024 WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, announced that its wholly owned subsidiary, Orion Acquisition AB (the “Buyer”), has extended the expiration time of the offering period of its previously […]
Data to be Presented Today at NGS Open Meeting Demonstrating Clinical Value of KidneyIntelX LONDON and SALT LAKE CITY, February 29, 2024 – Renalytix plc (NASDAQ: RNLX) (LSE: RENX) (“Renalytix” or the “Company”) announces that effective March 1, 2024, the United States Government has approved adding the company’s Food and Drug Administration (“FDA”) de Novo Marketing authorized test, kidneyintelX.dkd, to its […]
Funding Requests Life Sciences Initiative – Senator Ann Millner The original initiative requested the legislature provide $7.125M of ongoing funding to higher education in Utah to support the workforce needs of Utah’s Life Sciences industry. BioUtah has worked closely with Talent Ready Utah, colleges and universities in the state, and other stakeholders to create […]
Myriad’s Precise MRD test will be used to evaluate the broad applicability of MRD testing across many cancer types SALT LAKE CITY, Feb. 27, 2024 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced a research collaboration with the National Cancer Center Hospital East (NCCHE) in […]